Skip to Content


Sunshine Act Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The U. S. Chemical Safety and Hazard Investigation Board announces that it will convene a Public Meeting beginning at 10 a.m. local time on July 31, 2002, at 2175 K Street, NW., Suite 400 Conference Room, Washington DC. The Board will discuss and deliberate on staff recommendations regarding an update to the CSB strategic plan for FY 2003. The Board will also consider the status of recommendations from prior CSB investigations and the responses from recipients of those recommendations. Additionally, the CSB staff will present to the Board an update on the Reactive Chemical Hazards Investigation and the close of the public comment period following the public hearing held in Paterson, New Jersey, on May 30, 2002.

CSB investigators will also update the Board on the status of current CSB investigative efforts. The meeting will conclude with an update on current administrative and contracting matters and the resolution of on-going audit issues.

All staff presentations are preliminary and are intended solely to allow the Board to consider in a public forum the relevant issues and factors. No factual analyses, conclusions, or findings should be considered final.

The meeting is open to the public. Please notify CSB if a translator or interpreter is needed, 10 business days prior to the public meeting. For more information, please contact the Chemical Safety and Hazard Investigation Board at (202)-261-7600, or visit our website at:

Start Signature

Christopher W. Warner,

General Counsel.

End Signature End Preamble

[FR Doc. 02-18172 Filed 7-15-02; 2:04 pm]